Aligos Therapeutics's total assets for Q1 2026 were $64.56M, a decrease of -27.93% from the previous quarter. ALGS total liabilities were $32.77M for the fiscal quarter, a -9.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.